Listed

Vicarious Surgical Inc.: Form 10-Q for the period ended Sep 30, 2022

Filed with the SEC on Nov 7, 2022 and accepted by EDGAR at Nov 7, 2022, 17:12 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2022-07-01 to 2022-09-30$12.1mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2022-01-01 to 2022-09-30$32.0mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2022-07-01 to 2022-09-30−$22.2mus-gaap:OperatingIncomeLoss
Operating income9 months2022-01-01 to 2022-09-30−$59.5mus-gaap:OperatingIncomeLoss
Interest expense3 months2022-07-01 to 2022-09-30$31.0kus-gaap:InterestExpense
Interest expense9 months2022-01-01 to 2022-09-30$89.0kus-gaap:InterestExpense
Net income3 months2022-07-01 to 2022-09-30−$24.7mus-gaap:NetIncomeLoss
Net income9 months2022-01-01 to 2022-09-30$16.3mus-gaap:NetIncomeLoss
Diluted EPS3 months2022-07-01 to 2022-09-30−$0.20us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2022-01-01 to 2022-09-30$0.12us-gaap:EarningsPerShareDiluted
Basic EPS3 months2022-07-01 to 2022-09-30−$0.20us-gaap:EarningsPerShareBasic
Basic EPS9 months2022-01-01 to 2022-09-30$0.14us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2022-07-01 to 2022-09-30121,965,277 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2022-01-01 to 2022-09-30121,201,693 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2022-01-01 to 2022-09-30−$42.8mus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2022-09-30$126.8mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-09-30$131.3mus-gaap:AssetsCurrent
Total assetsAt period end2022-09-30$150.7mus-gaap:Assets
Current liabilitiesAt period end2022-09-30$11.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2022-09-30$41.7mus-gaap:Liabilities
Long-term debtAt period end2022-09-30$250.0kus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2022-09-30$109.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001213900-22-069803. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.